Clinical Trials Browser

Interventional × patritumab × Other solid neoplasm × Clear all

NCT01957280 2014-05-14

Study to Assess Pharmacokinetics, Immunogenicity and Safety/Tolerability of Patritumab (U3-1287)

Phase 1 Completed

Other solid neoplasm

Solid Tumors